Turkiewicz, K.; Kulczycki, J.J.; Rola, P.; Włodarczak, S.; Barycki, M.; Włodarczak, P.; Furtan, Ł.; Kozak, P.; Doroszko, A.; Banasiak, W.;
et al. Pre-Procedural Use of Levosimendan in High-Risk ACS-PCI Patients with Reduced Left Ventricle Ejection Fraction—Short-Term Outcomes. J. Clin. Med. 2025, 14, 2761.
https://doi.org/10.3390/jcm14082761
AMA Style
Turkiewicz K, Kulczycki JJ, Rola P, Włodarczak S, Barycki M, Włodarczak P, Furtan Ł, Kozak P, Doroszko A, Banasiak W,
et al. Pre-Procedural Use of Levosimendan in High-Risk ACS-PCI Patients with Reduced Left Ventricle Ejection Fraction—Short-Term Outcomes. Journal of Clinical Medicine. 2025; 14(8):2761.
https://doi.org/10.3390/jcm14082761
Chicago/Turabian Style
Turkiewicz, Karol, Jan Jakub Kulczycki, Piotr Rola, Szymon Włodarczak, Mateusz Barycki, Piotr Włodarczak, Łukasz Furtan, Paweł Kozak, Adrian Doroszko, Waldemar Banasiak,
and et al. 2025. "Pre-Procedural Use of Levosimendan in High-Risk ACS-PCI Patients with Reduced Left Ventricle Ejection Fraction—Short-Term Outcomes" Journal of Clinical Medicine 14, no. 8: 2761.
https://doi.org/10.3390/jcm14082761
APA Style
Turkiewicz, K., Kulczycki, J. J., Rola, P., Włodarczak, S., Barycki, M., Włodarczak, P., Furtan, Ł., Kozak, P., Doroszko, A., Banasiak, W., Lesiak, M., & Włodarczak, A.
(2025). Pre-Procedural Use of Levosimendan in High-Risk ACS-PCI Patients with Reduced Left Ventricle Ejection Fraction—Short-Term Outcomes. Journal of Clinical Medicine, 14(8), 2761.
https://doi.org/10.3390/jcm14082761
